83 related articles for article (PubMed ID: 12846176)
1. Nevirapine-based fixed-dose combination ARVs.
Meldrum J
GMHC Treat Issues; 2003 May; 17(5):5-9. PubMed ID: 12846176
[No Abstract] [Full Text] [Related]
2. High incidence of nevirapine-associated rash in HIV-infected Chinese.
Ho TT; Wong KH; Chan KC; Lee SS
AIDS; 1998 Oct; 12(15):2082-3. PubMed ID: 9814883
[No Abstract] [Full Text] [Related]
3. Negligence. Liver transplant patient too late to sue Viramune maker.
AIDS Policy Law; 2003 Mar; 18(6):7. PubMed ID: 12712930
[No Abstract] [Full Text] [Related]
4. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
Koh MT
Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
[No Abstract] [Full Text] [Related]
5. Nevirapine in children.
Proj Inf Perspect; 1998 Dec; (26):7. PubMed ID: 11366500
[TBL] [Abstract][Full Text] [Related]
6. Drugs for HIV infection.
Med Lett Drugs Ther; 2001 Nov; 43(1119):103-8. PubMed ID: 11723420
[No Abstract] [Full Text] [Related]
7. Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.
Reliquet V; Ferré V; Hascoet C; Besnier JM; Bellein V; Arvieux C; Molina JM; Breux JP; Zucman D; Rozenbaum W; Allavena C; Raffi F;
Antivir Ther; 1999; 4 Suppl 3():83-4. PubMed ID: 16021876
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.
Marier JF; Dimarco M; Guilbaud R; Dodard C; Morelli G; Tippabhotla SK; Singla AK; Thudi NR; Monif T
J Clin Pharmacol; 2007 Nov; 47(11):1381-9. PubMed ID: 17962426
[TBL] [Abstract][Full Text] [Related]
9. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Piyavong B; Chumpathat N; Chantratita W
Clin Infect Dis; 2007 Feb; 44(3):447-52. PubMed ID: 17205457
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE
Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness also in general practice conditions. Just as good in routine practice as in studies].
MMW Fortschr Med; 2000; 142(3 Suppl):36-7. PubMed ID: 10893965
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infection.
Getahun A; Tansuphasawadikul S; Desakorn V; Dhitavat J; Pitisuttithum P
J Med Assoc Thai; 2006 Sep; 89(9):1472-8. PubMed ID: 17100387
[TBL] [Abstract][Full Text] [Related]
13. Toxic epidermal necrolysis induced by nevirapine therapy: description of two cases and review of the literature.
Cattelan AM; Trevenzoli M; Sasset L; Sgarabotto D; Lanzafame M; Meneghetti F
J Infect; 2001 Nov; 43(4):246-9. PubMed ID: 11869062
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study.
Anekthananon T; Ratanasuwan W; Techasathit W; Sonjai A; Suwanagool S
J Med Assoc Thai; 2004 Jul; 87(7):760-7. PubMed ID: 15521230
[TBL] [Abstract][Full Text] [Related]
15. Nevirapine (Viramune).
Res Initiat Treat Action; 2000 Mar; 6(1):18-9. PubMed ID: 11708179
[No Abstract] [Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
[TBL] [Abstract][Full Text] [Related]
17. Europe warned of side effects.
AIDS Patient Care STDS; 2000 Jul; 14(7):395-6. PubMed ID: 10935057
[No Abstract] [Full Text] [Related]
18. Treatment of primary HIV infection: a pilot study of stavudine and didanosine plus nevirapine with or without hydroxyurea.
Zala C; Salomón H; Cahn P
Antivir Ther; 1999; 4 Suppl 3():95-9. PubMed ID: 16021880
[TBL] [Abstract][Full Text] [Related]
19. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.
Calmy A; Pinoges L; Szumilin E; Zachariah R; Ford N; Ferradini L;
AIDS; 2006 May; 20(8):1163-9. PubMed ID: 16691068
[TBL] [Abstract][Full Text] [Related]
20. New strides in protecting infants from HIV. Researchers continue quest to give pregnant women better options to prevent mother-to-child transmission.
Kresge KJ
IAVI Rep; 2005; 9(2):9-12. PubMed ID: 16156074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
